Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982319 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue
A Phase 2 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT00982319 is a Phase 2 study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 34 participants.
The verdict
NCT00982319, a Phase 2 study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this research is to examine the effect of a broccoli sprout preparation on specific factors in breast tissue that are related to breast cancer risk and to assess whether sulforaphane a key component of broccoli sprouts increases the levels of protective enzymes in breast tissue. In addition, the investigators will also examine how acceptable the broccoli sprouts preparation is to the study participants.
Interventions
- DRUG Broccoli sprout extract
- DRUG Mango juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982319
The ClinicalTrials.gov registry entry for NCT00982319 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Broccoli sprout extract is the first listed.
NCT00982319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00982319 about?
NCT00982319 is a clinical study titled "Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue". The purpose of this research is to examine the effect of a broccoli sprout preparation on specific factors in breast tissue that are related to breast cancer risk and to assess whether sulforaphane a key component of broccoli sprouts increases the levels of protective enzymes in breast tissue. In ad...
What is the current status of trial NCT00982319?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2009-04. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00982319?
The interventions under investigation include: Broccoli sprout extract (DRUG), Mango juice (DRUG).
Who is sponsoring clinical trial NCT00982319?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.